News – Efferon

03 November 2022

Efferon at LIVES 2022 in Paris

30 November 2021

Efferon has participated in MEDICA

26 November 2021

Efferon CT treatment improves patients with severe SARS-CoV-2

22 October 2020

Conferences in Moscow

29 April 2021

LASSO multicenter randomized trial launched

31 March 2021

Shipment to Latin America

Intensive Care Medicine Experimental 2022, 10(2): 000710

Extracorporeal hemoperfusion with Efferon LPS for rapid reconstitution of vital parameters and decreasing proinflammatory biomarkers in patients with intra-abdominal sepsis

Critical Care 2021, 25(Suppl 1): P041

Hemoperfusion with the Efferon CT extracorporeal adsorbers containing mesoporous styrene–divinylbenzene copolymer (SDC) in patients with severe COVID-19

World Journal of Medical Case Reports. Vol. 2, No. 3, 2021, pp. 46-50.

Application of novel device Efferon LPS in hemoperfusion for simultaneous removal of endotoxin and cytokines in a patient with septic shock

Therapeutic archive. 2021; 93 (7): 811-817

Extracorporeal adsorption of cytokines in cytokine release syndrome in a patient with acute lymphoblastic leukemia after therapy with T cells with a chimeric antigen receptor. Clinical observation

General resuscitation. 2020; 16 (6): 31-53.

Application of adsorbent based on a hypercrosslinked styrene-divinylbenzene copolymer with an immobilized LPS-selective ligand in hemoperfusion for the treatment of patients with septic shock

General resuscitation. 2020; 16 (4): 14-20.

Hemosorption carried out by a column filled with hypercrosslinked styrene-divinibenzene copolymer with an immobilized LPS-selective ligand in a complex of intensive treatment of acute lung injury in the surgical treatment of lung cancer (clinical observation)

General resuscitation. 2018; 14 (6): 51-60.

Efficiency and safety of a new product for LPS-selective hemosorption (experimental study)

General resuscitation. 2016; 12 (6): 82-107.

Sorbents for extracorporeal removal of toxic substances and molecules with unwanted biological activity (review)

General resuscitation. 2017; 13 (5): 109-120.

Methods for the determination of bacterial endotoxin in critical care medicine (review).

Invention patent RU 2691413 C1. Date of registration: 26.12.2017

Method for determination of bacterial endotoxin in biological fluids.